New inhibitors targeting bacterial RNA polymerase

Trends in Biochemical Sciences

Volumn 29, Issue 4, 2004, Pages 159-162

  Darst, Seth A ^a  

^a ROCKEFELLER UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 HYDROXY N' PHENYL 3 TRIFLUOROMETHYLBENZAMIDINE; ANTIINFECTIVE AGENT; BACTERIAL ENZYME; CBR 703; MICROCIN J25; RNA POLYMERASE; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; DRUG MECHANISM; DRUG STRUCTURE; DRUG TARGETING; ENZYME INHIBITION; HIGH THROUGHPUT SCREENING; NONHUMAN; PRIORITY JOURNAL; REVIEW;

BACTERIA (MICROORGANISMS);

EID: 1842713108     PISSN: 09680004     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tibs.2004.02.005     Document Type: Short Survey

References (27)

1. Darst S.A. Bacterial RNA polymerase. Curr. Opin. Struct. Biol. 11:2001;155-162.
2. Murakami K., Darst S.A. Bacterial RNA polymerases: the wholo story. Curr. Opin. Struct. Biol. 13:2003;31-39.
3. Sensi P., et al. Isolation and properties of rifomycin B and rifomycin complex. Antibiotics Ann. 1:1960;262-270.
4. Sensi P. History of the development of rifampin. Rev. Infect. Dis. 5:(Suppl. 3):1983;402-406.
5. Artsimovich I., et al. A new class of bacterial RNA polymerase inhibitor affects nucleotide addition. Science. 302:2003;650-654.
6. Delgado M.A., et al. Escherichia coli RNA polymerase is the target of the cyclopeptide antibiotic microcin J25. J. Bacteriol. 183:2001;4543-4550.
7. Yuzenkova J., et al. Mutations of bacterial RNA polymerase leading to resistance to microcin J25. J. Biol. Chem. 277:2002;50867-50875.
8. Zhang G., et al. Crystal structure of Thermus aquaticus core RNA polymerase at 3.3 Å resolution. Cell. 98:1999;811-824.
9. Gnatt A.L., et al. Structural basis of transcription: an RNA polymerase II elongation complex at 3.3 Å resolution. Science. 292:2001;1876-1882.
10. Cramer P., et al. Structural basis of transcription: RNA polymerase II at 2.8 Å resolution. Science. 292:2001;1863-1876.
11. Korzheva N., et al. A structural model of transcription elongation. Science. 289:2000;619-625.
12. Epshtein V., et al. Swing-gate model of nucleotide entry into the RNA polymerase active center. Mol. Cell. 10:2002;623-634.
13. Campbell E.A., et al. Structural mechanism for rifampicin inhibition of bacterial RNA polymerase. Cell. 104:2001;901-912.
14. McClure W.R., Cech C.L. On the mechanism of rifampicin inhibition of RNA synthesis. J. Biol. Chem. 253:1978;8949-8956.
15. Cassani G., et al. Inhibition of RNA polymerase by streptolydigin. Nat. New Biol. 230:1971;197-200.
16. Heisler L.M., et al. Four contiguous amino acids define the target for streptolydigin resistance in the β subunit of Escherichia coli RNA polymerase. J. Biol. Chem. 268:1993;25369-25375.
17. Severinov K., et al. Streptolydigin-resistant mutants in an evolutionarily conserved region of the β′ subunit of Escherichia coli RNA polymerase. J. Biol. Chem. 270:1995;23926-23929.
18. Bushnell D.A., et al. Structural basis of transcription: α-amanitin-RNA polymerase II cocrystal at 2.8 Å resolution. Proc. Natl. Acad. Sci. U. S. A. 99:2002;1218-1222.
19. Blond A., et al. The cyclic structure of microcin J25, a 21-residue peptide antibiotic from Escherichia coli. Eur. J. Biochem. 259:1999;747-755.
20. Salomon R.A., Farias R.N. Microcin-25, a novel antimicrobial peptide produced by Escherichia coli. J. Bacteriol. 174:1992;7428-7435.
21. Solbiati J.O., et al. Sequence analysis of the four plasmid genes required to produce the circular peptide antibiotic microcin J25. J. Bacteriol. 181:1999;2659-2662.
22. Wilson K.-A., et al. The structure of microcin J25, a peptide inhibitor of bacterial RNA polymerase, is a lassoed tail. J. Am. Chem. Soc. 125:2003;12475-12483.
23. Rosengren K.J., et al. Microcin J25 has a threaded sidechain-to-backbone ring structure and not a head-to-tail cyclized backbone. J. Am. Chem. Soc. 125:2003;12464-12474.
24. Bayro M.J., et al. Structure of the antibacterial peptide microcin J25: A 21-residue lariat protoknot. J. Am. Chem. Soc. 125:2003;12382-12383.
25. Ramaswamy S., Musser J.M. Molecular genetic basis of antimicrobial agent resistance in Mycobacterium tuberculosis: 1998 update. Tuber. Lung Dis. 79:1998;3-29.
26. Rinehart K.L.J., et al. Structure of streptolydigin. Antimicrob. Agents Chemother. 161:1963;346-348.
27. Opalka N., et al. Structure and function of the transcription elongation factor GreB bound to bacterial RNA polymerase. Cell. 114:2003;335-345.